We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DNA-Purification Kit

By Biotechdaily staff writers
Posted on 14 Dec 2005
A new DNA-purification kit uses novel chemistry and column design to purify DNA that is virtually devoid of RNA and protein contamination.

The versaGene DNA cell purification kit was developed by Gentra Systems, Inc. More...
(Minneapolis, MN, USA). The kit is highly scalable and allows purification of very high-quality, double-stranded DNA from as few as 1,000 and up to 25 million cells from the same kit, in as little as 30 minutes. Eluted samples can be used immediately in downstream applications. These include applications such as single nucleotide polymorphisms (SNPs) and comparative genomic hybridization (CGH) microarrays. Researchers performing CGH assays to aid in the early diagnosis of cancer and genetic diseases also represent a market for the new kit.

"As the need for personalized medicine grows, with its emphasis on individual human genotype mapping, so too grows the need to reduce sample failure in downstream applications,” noted Stephen Rundlett, product manager, versaGene. "Based on our own stringent product development test results, versaGene for DNA Cells does indeed deliver markedly superior performance in even the most demanding applications.”

Gentra Systems is a leading provider of nucleic acid purification technology, instrumentation, and innovation to the global life sciences industries. Product lines include pureGene kits as well as autopure and autotech instruments.




Related Links:
Gentra Systems

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Aspiration System
VACUSAFE
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.